Last 12 months
Inside the activity.
16 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 3 | 0 |
| Jan 2026 | 3 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 1 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 27, 2023 Filed Sep 27, 2023 23:53 UTC |
Dwyer DonaldChief Business Officer
|
PurchaseCommon Stock | 1,000 | $1.01 | $1,010.00 |
DisclosureSEC source: 0001753926-23-001275 · ownership.xml · nonDerivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,000 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| September 26, 2023 Filed Sep 27, 2023 23:51 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 1,567 | $0.94 | $1,472.98 |
DisclosureSEC source: 0001753926-23-001273 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,307 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| September 25, 2023 Filed Sep 27, 2023 23:51 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 24,088 | $0.95 | $22,883.60 |
DisclosureSEC source: 0001753926-23-001273 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,740 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| September 21, 2023 Filed Sep 23, 2023 00:34 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 398 | $0.93 | $370.14 |
DisclosureSEC source: 0001753926-23-001254 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,652 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| September 20, 2023 Filed Sep 23, 2023 00:34 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 21,028 | $0.92 | $19,345.76 |
DisclosureSEC source: 0001753926-23-001254 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,254 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| September 18, 2023 Filed Sep 18, 2023 23:46 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 66,743 | $0.96 | $64,073.28 |
DisclosureSEC source: 0001753926-23-001243 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,226 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 23:46 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 35,036 | $0.95 | $33,284.20 |
DisclosureSEC source: 0001753926-23-001243 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,483 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| September 12, 2023 Filed Sep 13, 2023 01:12 UTC |
Williams GreggDirector
|
PurchaseCommon Stock | 5,145 | $0.96 | $4,939.20 |
DisclosureSEC source: 0001753926-23-001215 · ownership.xml · nonDerivative · entry 3 Williams Gregg · CIK 0001624919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,447 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| September 11, 2023 Filed Sep 13, 2023 01:12 UTC |
Williams GreggDirector
|
PurchaseCommon Stock | 1,854 | $0.95 | $1,761.30 |
DisclosureSEC source: 0001753926-23-001215 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,302 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| September 08, 2023 Filed Sep 13, 2023 01:12 UTC |
Williams GreggDirector
|
PurchaseCommon Stock | 6,998 | $0.94 | $6,578.12 |
DisclosureSEC source: 0001753926-23-001215 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,448 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| September 07, 2023 Filed Sep 7, 2023 22:17 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 33,700 | $0.94 | $31,678.00 |
DisclosureSEC source: 0001753926-23-001198 · ownership.xml · nonDerivative · entry 3 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,450 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| September 06, 2023 Filed Sep 7, 2023 22:17 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 14,570 | $0.94 | $13,695.80 |
DisclosureSEC source: 0001753926-23-001198 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,750 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| September 05, 2023 Filed Sep 7, 2023 22:17 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 4,997 | $0.93 | $4,647.21 |
DisclosureSEC source: 0001753926-23-001198 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,180 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| September 01, 2023 Filed Sep 2, 2023 01:24 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 10,888 | $0.94 | $10,234.72 |
DisclosureSEC source: 0001753926-23-001183 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,183 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 23:04 UTC |
Makes BrigidCFO
|
PurchaseCommon Stock | 4,000 | $0.95 | $3,780.00 |
DisclosureSEC source: 0001753926-23-001190 · ownership.xml · nonDerivative · entry 2 Makes Brigid · CIK 0001375927 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| August 31, 2023 Filed Sep 2, 2023 01:24 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 5,295 | $0.92 | $4,871.40 |
DisclosureSEC source: 0001753926-23-001183 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,295 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| August 31, 2023 Filed Sep 5, 2023 23:06 UTC |
Dwyer DonaldChief Business Officer
|
PurchaseCommon Stock | 7,500 | $0.94 | $7,050.00 |
DisclosureSEC source: 0001753926-23-001192 · ownership.xml · nonDerivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| August 31, 2023 Filed Sep 5, 2023 23:04 UTC |
Makes BrigidCFO
|
PurchaseCommon Stock | 2,000 | $0.90 | $1,800.00 |
DisclosureSEC source: 0001753926-23-001190 · ownership.xml · nonDerivative · entry 1 Makes Brigid · CIK 0001375927 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 F1 · kind: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 18:43 UTC |
Dwyer DonaldChief Business Officer
|
PurchaseCommon Stock | 7,500 | $1.08 | $8,100.00 |
DisclosureSEC source: 0001753926-23-001082 · ownership.xml · nonDerivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| June 28, 2023 Filed Jun 29, 2023 16:43 UTC |
Makes BrigidCFO
|
PurchaseCommon Stock | 3,000 | $1.21 | $3,630.00 |
DisclosureSEC source: 0001753926-23-000869 · ownership.xml · nonDerivative · entry 2 Makes Brigid · CIK 0001375927 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| June 27, 2023 Filed Jun 29, 2023 16:43 UTC |
Makes BrigidCFO
|
PurchaseCommon Stock | 1,000 | $1.24 | $1,240.00 |
DisclosureSEC source: 0001753926-23-000869 · ownership.xml · nonDerivative · entry 1 Makes Brigid · CIK 0001375927 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the open market. The reporting person undertakes to provide to Vivani Medical, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. Read SEC document |
| June 22, 2023 Filed Jun 26, 2023 15:03 UTC |
Dwyer DonaldChief Business Officer
|
PurchaseCommon Stock | 5,000 | $1.24 | $6,200.00 |
DisclosureSEC source: 0001753926-23-000850 · ownership.xml · nonDerivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 F1 · kind: Individual purchased shares on the open market. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 19:27 UTC |
Baker Wilford DeanDirector
|
GrantCommon Stock Option · Derivative | 32,121 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001753926-23-000811 · form_4.xml · derivative · entry 1 Baker Wilford Dean · CIK 0001377879 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,121 Underlying: Common Stock · 32,121 shares Expires 2033-06-15 F2 · derivative.exercise_date: Options vest monthly over a one-year period F1 · balance_after: Awarded as compensation for serving on the Board of Directors. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 23:33 UTC |
Williams GreggDirector · 10% owner
|
GrantCommon Stock Option · Derivative | 32,121 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001753926-23-000817 · form_4.xml · derivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,121 Underlying: Common Stock · 32,121 shares Expires 2033-06-15 F2 · derivative.exercise_date: Options vest monthly over a one-year period. F1 · balance_after: Awarded as compensation for serving on The Board of Directors and its committees. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 23:31 UTC |
Mendelsohn AaronDirector
|
GrantCommon Stock Option · Derivative | 32,121 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001753926-23-000815 · form_4.xml · derivative · entry 1 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,121 Underlying: Common Stock · 32,121 shares Expires 2033-06-15 F2 · derivative.exercise_date: Options vest monthly over a one-year period. F1 · balance_after: Awarded as compensation for serving on the Board of Directors. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 23:29 UTC |
Popoff Alexandra L.Director
|
GrantCommon Stock Option · Derivative | 32,121 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001753926-23-000813 · form_4.xml · derivative · entry 1 Larson Alexandra L.P. · CIK 0001858534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,121 Underlying: Common Stock · 32,121 shares Expires 2033-06-15 F2 · derivative.exercise_date: Options vest monthly over a one-year period. F1 · balance_after: Awarded as compensation for serving on the Board of Directors. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 01:32 UTC |
Mendelsohn AaronDirector
|
PurchaseCommon Stock | 10,000 | $1.30 | $12,980.00 |
DisclosureSEC source: 0001753926-23-000794 · form_4.xml · nonDerivative · entry 1 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,170 F1 · ownership.direct: Represents shares of common stock purchased by Mr. Mendelsohn on the open market. Read SEC document |
| April 28, 2023 Filed May 1, 2023 21:00 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 1,632,330 | $1.10 | $1,795,563.00 |
DisclosureSEC source: 0001753926-23-000563 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 13,677,308 F2 · price: These shares were purchased from a private party at a price of $1.10 per share on April 28, 2023. F3 · ownership.nature: Includes (i) 11,551,556 shares of common stock owned by Gregg G. Williams 2006 Trust, (ii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iii) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (iv) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Greg Williams has voting and dispositive power over all of these shares. Read SEC document |
| April 27, 2023 Filed May 1, 2023 21:00 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 408,164 | $0.98 | $400,000.72 |
DisclosureSEC source: 0001753926-23-000563 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 12,044,978 F1 · price: These shares were purchased from a private party at a price of $0.98 per share on April 27, 2023 F3 · ownership.nature: Includes (i) 11,551,556 shares of common stock owned by Gregg G. Williams 2006 Trust, (ii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iii) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (iv) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Greg Williams has voting and dispositive power over all of these shares. Read SEC document |
| April 18, 2023 Filed Apr 19, 2023 23:11 UTC |
Popoff Alexandra L.Director
|
GrantCommon Stock | 1,967 | $1.05 | $2,065.35 |
DisclosureSEC source: 0001753926-23-000483 · ownership.xml · nonDerivative · entry 2 Larson Alexandra L.P. · CIK 0001858534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,166 F1 · price: Shares acquired in open market transaction Read SEC document |
| April 17, 2023 Filed Apr 19, 2023 23:11 UTC |
Popoff Alexandra L.Director
|
GrantCommon Stock | 33 | $1.05 | $34.65 |
DisclosureSEC source: 0001753926-23-000483 · ownership.xml · nonDerivative · entry 1 Larson Alexandra L.P. · CIK 0001858534 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199 F1 · price: Shares acquired in open market transaction Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 02:32 UTC |
Mendelsohn AdamDirector · CEO
|
GrantRSU · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-23-000259 · ownership.xml · derivative · entry 2 Mendelsohn Adam · CIK 0001940008 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-03-06 F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock. F3 · shares: First third of RSUs vest when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after the second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 02:32 UTC |
Mendelsohn AdamDirector · CEO
|
GrantCommon Stock Option · Derivative | 200,000 | $0.00 Strike: $1.09 | $0.00 |
DisclosureSEC source: 0001753926-23-000259 · ownership.xml · derivative · entry 1 Mendelsohn Adam · CIK 0001940008 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2033-03-06 F2 · shares: The stock options have a 10-year term and vest immediately when share price closes at $6.30 for three consecutive business days. If the options fail to reach $6.30 for three consecutive business days within a four year term from the date of grant the options expire. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 02:36 UTC |
Dwyer DonaldChief Business Officer
|
GrantRSUs · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-23-000267 · ownership.xml · derivative · entry 2 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-03-06 F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock. F2 · derivative.exercise_date: The performance based RSUs vest one third when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 02:36 UTC |
Dwyer DonaldChief Business Officer
|
GrantRSUs · Derivative | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-23-000267 · ownership.xml · derivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2027-03-06 F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock. F2 · derivative.exercise_date: The performance based RSUs vest one third when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 02:35 UTC |
Le TrucCOO
|
GrantRSUs · Derivative | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-23-000265 · ownership.xml · derivative · entry 1 Le Truc · CIK 0001940176 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2027-03-06 F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock. F2 · derivative.exercise_date: The performance based RSUs vest one third when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 02:34 UTC |
Porter Lisa EllenChief Medical Officer
|
GrantRSUs · Derivative | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-23-000263 · ownership.xml · derivative · entry 2 Porter Lisa Ellen · CIK 0001940462 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-03-06 F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock. F2 · derivative.exercise_date: The performance based RSUs vest one third when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 02:34 UTC |
Porter Lisa EllenChief Medical Officer
|
GrantRSUs · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-23-000263 · ownership.xml · derivative · entry 1 Porter Lisa Ellen · CIK 0001940462 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-03-06 F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock. F2 · derivative.exercise_date: The performance based RSUs vest one third when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 02:33 UTC |
Makes BrigidCFO
|
GrantRSUs · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-23-000261 · ownership.xml · derivative · entry 2 Makes Brigid · CIK 0001375927 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2027-03-06 F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock. F2 · derivative.exercise_date: The performance based RSUs vest one third when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 02:33 UTC |
Makes BrigidCFO
|
GrantRSUs · Derivative | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-23-000261 · ownership.xml · derivative · entry 1 Makes Brigid · CIK 0001375927 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2027-03-06 F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock. F2 · derivative.exercise_date: The performance based RSUs vest one third when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 23:42 UTC |
Mendelsohn AdamDirector · CEO
|
GiftCommon Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-23-000124 · ownership.xml · nonDerivative · entry 1 Mendelsohn Adam · CIK 0001940008 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,605,015 F1 · kind: Represents shares of common stock gifted to a non-family member. Read SEC document |
| January 19, 2023 Filed Jan 24, 2023 02:13 UTC |
Mendelsohn AdamDirector · CEO
|
GrantCommon Stock Option · Derivative | 200,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001753926-23-000082 · ownership.xml · derivative · entry 1 Mendelsohn Adam · CIK 0001940008 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2033-01-19 F1 · shares: The stock options have a 10-year term and vest 25% at one-year and monthly for 36 months thereafter on an equal basis. Read SEC document |
| January 19, 2023 Filed Jan 24, 2023 02:11 UTC |
Makes BrigidCFO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001753926-23-000080 · ownership.xml · derivative · entry 2 Makes Brigid · CIK 0001375927 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-01-19 F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one year and monthly for 36 months thereafter on a equal basis. Read SEC document |
| January 19, 2023 Filed Jan 24, 2023 02:11 UTC |
Makes BrigidCFO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001753926-23-000080 · ownership.xml · derivative · entry 1 Makes Brigid · CIK 0001375927 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-01-19 F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one year and monthly for 36 months thereafter on a equal basis. Read SEC document |
| January 19, 2023 Filed Jan 24, 2023 02:09 UTC |
Dwyer DonaldChief Business Officer
|
GrantCommon Stock Option · Derivative | 70,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001753926-23-000078 · ownership.xml · derivative · entry 2 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2033-01-19 F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly for 36 months thereafter on an equal basis. Read SEC document |
| January 19, 2023 Filed Jan 24, 2023 02:09 UTC |
Dwyer DonaldChief Business Officer
|
GrantCommon Stock Option · Derivative | 30,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001753926-23-000078 · ownership.xml · derivative · entry 1 Dwyer Donald · CIK 0001940425 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-01-19 F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly for 36 months thereafter on an equal basis. Read SEC document |
| January 19, 2023 Filed Jan 24, 2023 02:08 UTC |
Porter Lisa EllenChief Medical Officer
|
GrantCommon Stock Option · Derivative | 40,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001753926-23-000076 · ownership.xml · derivative · entry 2 Porter Lisa Ellen · CIK 0001940462 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-01-19 F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly for 36 months thereafter on an equal basis. Read SEC document |
| January 19, 2023 Filed Jan 24, 2023 02:08 UTC |
Porter Lisa EllenChief Medical Officer
|
GrantCommon Stock Option · Derivative | 80,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001753926-23-000076 · ownership.xml · derivative · entry 1 Porter Lisa Ellen · CIK 0001940462 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2033-01-19 F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly for 36 months thereafter on an equal basis. Read SEC document |
| January 19, 2023 Filed Jan 24, 2023 02:06 UTC |
Le TrucCOO
|
GrantCommon Stock Option · Derivative | 160,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001753926-23-000074 · ownership.xml · derivative · entry 1 Le Truc · CIK 0001940176 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2033-01-19 F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly for 36 months thereafter on an equal basis. Read SEC document |
| January 03, 2023 Filed Apr 25, 2023 21:50 UTC |
Bolck Joachim Eberhard10% owner
|
PurchaseCommon Stock | 10,000 | $0.90 | $9,000.00 |
DisclosureSEC source: 0001753926-23-000518 · ownership.xml · nonDerivative · entry 3 Bolck Joachim Eberhard · CIK 0001974849 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,524,229 F2 · ownership.nature: Joachim and Yaeko Bolck as conservators for Yasuo Saito Bolck. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.